Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
about
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control studyAntibiotic strategies in the era of multidrug resistanceTransmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferencePredictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant EnterobacteriaceaeOutbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions.2013 WSES guidelines for management of intra-abdominal infections.Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore.Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy.Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensionsThe emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors.Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.Risk factors for the acquisition of OXA-48-producing Enterobacteriaceae in a hospital outbreak setting: a matched case-control study.Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes.Epidemiology and economics of adult patients hospitalized with urinary tract infections.Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors.Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.Global antimicrobial resistance: from surveillance to stewardship. Part 1: surveillance and risk factors for resistance.
P2860
Q21134706-4BC9911A-DC2D-4BDD-9B76-DE519DB20CCEQ26744091-927470CA-050E-4495-B57B-F7295C85708DQ31079504-11277DCF-7B15-4995-BFE6-292236C09725Q33640559-CD35A104-DFF9-44CA-83B4-7955B6D7D1D4Q33798081-669DFAE1-F309-465F-85A4-E14A65452B0AQ33816217-27F1A894-BE56-45E8-909B-4E5DDF35A756Q34298437-3EBB3BDD-822E-42F3-A638-6D3B70F3BE60Q34321150-5DDAA954-1BBB-4D97-B59D-06D140981BA8Q35769401-2CDE985E-F84A-4191-9D76-9341FF78EB63Q35964808-203789CA-6173-4CEB-8738-42F0245203CDQ36150730-AF986BE9-988A-4425-BD44-CA0EA7A263E9Q36251683-18C9AA3D-D1AD-4415-8E78-EE8B2A212AD5Q36361921-508CE774-18BF-441D-837C-D6FB255E7BE9Q37569441-857C9481-1404-41F5-8303-FA91A5098772Q38068604-E5D36784-9C1A-48E8-8284-F4665FB390C8Q38083315-CF1D96E1-CC14-4DB7-8127-D56198D9C285Q38875303-970D65F5-873C-4ECD-9EE0-9CE930CC6A3AQ38934524-C4D4F7F8-E20B-4D7A-85ED-AECC058A23DDQ40206115-767DD059-5BA9-4C32-8096-29300104265BQ40530202-EEFBABCA-F20F-4799-89A1-51C98F871D11Q42225305-94B61D24-35B1-4668-9741-FDA82677BE44Q42930238-EDE317B3-B0DC-484F-A8C4-9DB8BBC15510Q44022634-1251D440-93EF-4F49-9B1F-04C2F9A535EEQ47691359-A038BD2F-8265-4314-92DA-CC7FEA9EF5ABQ47703240-2DA48FAC-CB19-4CC2-B3B2-1C7C28AE1B71Q51201051-2E65640F-FFBD-4A02-827F-403E4505F16C
P2860
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@en
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@nl
type
label
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@en
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@nl
prefLabel
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@en
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
@nl
P2093
P2860
P356
P1476
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae
@en
P2093
Amanda Dihmess
Benjamin Woo
Eileen Graffunder
Louise-Anne McNutt
Mallory Fiorenza
Pearl Martis
Rasha Masoud
Susan Harrington
Thomas P Lodise
P2860
P304
P356
10.1093/JAC/DKR156
P407
P50
P577
2011-04-19T00:00:00Z